EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses

Gilmara Barros de Lima iD, Everton Nencioni, Fábio Thimoteo, Camila Perea, Rafaela Fuzaro Alves Pinto, Sergio Daishi Sasaki iD

Biomolecules · 07.01.2025 · 15 (1) · 75

DOI: 10.3390/biom15010075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.01.2025. Verfasst von Gilmara Barros de Lima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program of Biosystems, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC (UFABC), São Bernardo do Campo, São Paulo 09606-04…. Hauptthemen laut MEDLINE: Serine Endopeptidases, Influenza, Human. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)—Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TMPRSS2, a human transmembrane protease enzyme, plays a crucial role in the spread of certain viruses, including influenza and coronaviruses. This enzyme promotes viral infection by cleaving viral glycoproteins, which helps viruses like SARS-CoV-2 and influenza A enter cells more effectively. Genetic differences in TMPRSS2 may affect people’s susceptibility to COVID-19, underscoring the need for studies that consider diverse populations. Beyond infectious diseases, TMPRSS2 has also been linked to some cancers, suggesting it could be a valuable target for drug development. This review provides a summary of TMPRSS2 inhibitors currently under study, with some already in clinical trials to test their effectiveness against viral infections. As we uncover more about TMPRSS2’s role in pathogenesis, it could open new doors for therapies to combat future outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine EndopeptidasesInfluenza, HumanHumansSARS-CoV-2Antiviral AgentsCOVID-19COVID-19 Drug TreatmentAnimals

Stichwörter der Autor:innen

TMPRSS2coronavirusinfluenzaserine proteinase inhibitors

Substanzen

TMPRSS2 protein, humanSerine EndopeptidasesAntiviral Agents

Autor:innen und Institutionen

  • Graduate Program of Biosystems, Centro de Ciências Naturais e Humanas, Universidade Federal do ABC (UFABC), São Bernardo do Campo, São Paulo 09606-045, Brazil.

ORCID-Profile: Gilmara Barros de Lima, Sergio Daishi Sasaki

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)—Brazil
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)—Brazil

Zitieren

APA

Barros de Lima, G., Nencioni, E., Thimoteo, F., Perea, C., Pinto, R. F. A., & Sasaki, S. D. (2025). TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses. Biomolecules, 15(1), 75. https://doi.org/10.3390/biom15010075

Vancouver

Barros de Lima G, Nencioni E, Thimoteo F, Perea C, Pinto RFA, Sasaki SD. TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses. Biomolecules. 2025;15(1):75. doi:10.3390/biom15010075

BibTeX
@article{BarrosdeLima2025,
  author = {Barros de Lima, Gilmara and Nencioni, Everton and Thimoteo, Fábio and Perea, Camila and Pinto, Rafaela Fuzaro Alves and Sasaki, Sergio Daishi},
  title = {TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {75},
  doi = {10.3390/biom15010075}
}
Kostenlos starten →